Julia, A, Gomez, A, Lopez-Lasanta, M, Blanco, F, Erra, A, Fernandez-Nebro, A, Mas, AJ, Perez-Garcia, C, Vivar, MLG, Sanchez-Fernandez, S, Alperi-Lopez, M, Sanmarti, R, Ortiz, AM, Fernandez-Cid, CM, Diaz-Torne, C, Moreno, E, Li, TL, Martinez-Mateu, SH, Absher, DM, Myers, RM, Molina, JT, Marsal, S. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis. EBioMedicine. 2022; 80DOI:10.1016/j.ebiom.2022.104053. PMID:35576644. IF:11.100(Q1/1D).

Herrera-Luis, E, Ortega, VE, Ampleford, EJ, Sio, YY, Granell, R, de Roos, E, Terzikhan, N, Vergara, EE, Hernandez-Pacheco, N, Perez-Garcia, J, Martin-Gonzalez, E, Lorenzo-Diaz, F, Hashimoto, S, Brinkman, P, Jorgensen, AL, Yan, Q, Forno, E, Vijverberg, SJ, Lethem, R, Espuela-Ortiz, A, Gorenjak, M, Eng, C, Gonzalez-Perez, R, Hernandez-Perez, JM, Poza-Guedes, P, Sardon, O, Corcuera, P, Hawkins, GA, Marsico, A, Bahmer, T, Rabe, KF, Hansen, G, Kopp, MV, Rios, R, Cruz, MJ, Gonzalez-Barcala, FJ, Olaguibel, JM, Plaza, V, Quirce, S, Canino, G, Cloutier, M, Del Pozo, V, Rodriguez-Santana, JR, Korta-Murua, J, Villar, J, Potocnik, U, Figueiredo, C, Kabesch, M, Mukhopadhyay, S, Pirmohamed, M, Hawcutt, DB, Melen, E, Palmer, CN, Turner, S, Maitland-van der Zee, AH, von Mutius, E, Celedon, JC, Brusselle, G, Chew, FT, Bleecker, E, Meyers, D, Burchard, EG, Pino-Yanes, M. Multi-ancestry genome-wide association study of asthma exacerbations. PEDIATRIC ALLERGY AND IMMUNOLOGY. 2022; 33(6)DOI:10.1111/pai.13802. PMID:35754128. IF:4.400(Q1/1D).

Arriola, E, Gonzalez-Cao, M, Domine, M, De Castro, J, Cobo, M, Bernabe, R, Navarro, A, Sullivan, I, Trigo, JM, Mosquera, J, Crama, L, Isla, D. Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis. Oncology And Therapy. 2022; 10(1)DOI:10.1007/s40487-021-00182-0. PMID:35032007. IF:(Q/D).

Majem, M, Goldman, JW, John, T, Grohe, C, Laktionov, K, Kim, SW, Kato, T, Vu, HV, Lu, S, Li, SQ, Lee, KY, Akewanlop, C, Yu, CJ, de Marinis, F, Bonanno, L, Domine, M, Shepherd, FA, Atagi, S, Zeng, LM, Kulkarni, D, Medic, N, Tsuboi, M, Herbst, RS, Wu, YL. Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial. CLINICAL CANCER RESEARCH. 2022; 28(11)DOI:10.1158/1078-0432.CCR-21-3530. PMID:35012927. IF:11.500(Q1/1D).